Putnam

Join us at our poster sessions at ISPOR Europe this November. Get in touch with us to connect live and learn more: https://lnkd.in/eAmW-D3r #ISPOREurope #ISPOREU2024 #MarketAccess #HTA #EvidenceGeneration #RWE #Biostatistics #PRO #Modelling

At Putnam, demand estimation studies are a cornerstone of our strategic advisory services. Each year, we conduct over 50 studies globally, integrating our findings into broader product strategies to ensure clients can make informed decisions about future demand. Our proprietary Demand Calibration Tool leverages machine learning and decades of expertise to fine-tune market research data, ensuring precise and actionable demand estimates. Discover how we help clients unlock deeper insights and shape strategic outcomes: https://lnkd.in/eJb4vQ6H #DemandEstimation #MarketResearch #AI #LifeSciences #PutnamStrategy

Are you attending ISPOR Europe in November? Get in touch with one of our experts. Learn more: https://lnkd.in/eAmW-D3r #ISPOREurope #ISPOREU2024 #MarketAccess #HTA #EvidenceGeneration #RWE #Biostatistics #PRO #Modelling

In our latest insight, our CEO Remco op den Kelder, shares three key observations from our two-year AI journey and how it’s reshaping the way we think, operate, and deliver value to clients. From enhancing decision-making to improving operational efficiency, AI’s impact is only growing. Read the full article to learn about the real-world applications and strategies that are helping Putnam lead in this AI-driven landscape: https://lnkd.in/ekUufshT #Pharma #AI #LifeSciences #PharmaInnovation #NavigateWithCertainty

We're attending and exhibiting at ISPOR EU 2024 this November in Barcelona where several team experts are ready to connect live. We'll have poster sessions across the duration of the conference, with some other key highlights. Find us at booth #1307. Learn more about our participation and expertise: https://lnkd.in/dqjnykPs #ISPOREurope #ISPOREU2024 #MarketAccess #HTA #EvidenceGeneration #RWE #Biostatistics #PRO #Modeling

Unlock actionable insights faster with ClarityNav, a cutting-edge proprietary AI tool designed to analyze and classify medical insights from multiple sources. Powered by GenAI, ClarityNav helps our experts refine strategies and identify impact metrics aligned with your goals. Get custom dashboards, AI-driven themes, and the ability to review vast volumes of data quickly and accurately. Find clarity and drive better decision-making for your medical affairs with tailored, scalable insights: https://lnkd.in/ezBXXwu2 #AI #MedicalAffairs #DataDriven #NavigateWithCertainty

Exciting times in #MedicalAffairs as we explore the cutting-edge potential of AI! Join the upcoming webinar: "Harnessing AI for Medical Insights" hosted by Medical Affairs Professional Society (MAPS) on October 3rd. Discover how artificial intelligence is transforming the way we generate, analyze, and leverage medical insights for better patient outcomes. Putnam's Lori Klein, PharmD, Partner, Medical & Scientific Affairs Practice Lead is a featured speaker. Register here: https://lnkd.in/eaXZsNnt #AI #MedicalAffairs #Healthcare #Webinar

At Putnam, we’re leveraging artificial intelligence to drive smarter decision-making, boost efficiency, and deliver cutting-edge solutions for our clients. Discover how our AI expertise is reshaping the life sciences landscape and learn about our approach: https://lnkd.in/eu2pTnxG #Pharma #AI #LifeSciences #PharmaInnovation #NavigateWithCertainty

We're heading to the Medical Affairs Strategic Summit (MASS) West this week! We're excited to be attending this event that brings together industry leaders to drive innovation in Medical Affairs and beyond. Reach out to schedule a meeting with Lori Klein, PharmD or Neelesh Chudasama, MD: https://lnkd.in/ezVEWuMg #MASSWest #MedicalAffairs #Pharma #LifeSciences

The EU's Joint Clinical Assessment (JCA) is fast-approaching. The complex terrain and significant impact to come is becoming more apparent. Navigating this new landscape requires not just understanding the process, but also strategic foresight and expert guidance. That's where we come in - a strategic market access partner to help you unlock JCA success. See our latest resource by Clément François and Ulrike Kuchenbecker to learn more: https://lnkd.in/eTdDUq_w #MarketAccess #JCA #HealthcareStrategy #Pharma #RegulatoryAffairs #Biopharma